Effects of fluoxetine and venlafaxine on serum brain derived neurotrophic factor levels in depressed patients
Authors:
- Ayse Devrim BaşterziABAyse Devrim Başterzi
- Kemal YaziciKYKemal Yazici
- Eda AslanEAEda Aslan
- Nuran DelialioğluNDNuran Delialioğlu
- Bahar TaşdelenBTBahar Taşdelen
- Şenel Tot AcarŞAŞenel Tot Acar
- Aylin YaziciAYAylin Yazici
- 1 March 2009
- journal article
- research article
- Published by Elsevier in Progress in Neuro-Psychopharmacology and Biological Psychiatry
- Vol. 33 (2) , 281-285
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Serum Brain-Derived Neurotrophic Factor, Depression, and Antidepressant Medications: Meta-Analyses and ImplicationsBiological Psychiatry, 2008
- Serum neurotrophins—A study on the time course and influencing factors in a large old age sampleNeurobiology of Aging, 2007
- Consensus paper of the WFSBP Task Force on Biological Markers: Biological Markers in DepressionThe World Journal of Biological Psychiatry, 2007
- Differentiating antidepressants of the future: Efficacy and safetyPharmacology & Therapeutics, 2007
- Genetic Variant BDNF (Val66Met) Polymorphism Alters Anxiety-Related BehaviorScience, 2006
- Partial Normalization of Serum Brain-Derived Neurotrophic Factor in Remitted Patients after a Major Depressive EpisodeNeuropsychobiology, 2005
- Hippocampal Brain-Derived Neurotrophic Factor Expression Following Treatment with Reboxetine, Citalopram, and Physical ExerciseNeuropsychopharmacology, 2004
- Transport of brain-derived neurotrophic factor across the blood–brain barrierNeuropharmacology, 1998
- Antidepressant-Like Effect of Brain-derived Neurotrophic Factor (BDNF)Pharmacology Biochemistry and Behavior, 1997
- Neurotrophins and Neuronal PlasticityScience, 1995